Breaking News Bar

Business News and Information

Pfizer and BioNTech Stock Price Jump on COVID Vaccine News

Pandemic and election news the past week has had a huge impact on market leaders like Pfizer (PFE), BioNTech (BNTX), Zoom Technologies (ZM), Canopy Growth (CGC), and Beyond Meat (BYND).

Pfizer (PFE) & BioNTech (BNTX)

Pfizer (PFE) and BioNTech (BNTX) were explosive earlier this week.  All on the news PFE just said its COVID-19 vaccine is 90% effective.  “Amazing news from Pfizer with 90% efficacy. This hopefully is the beginning of the end of our fight against Covid,” Peter Boockvar, chief investment officer at Bleakley Advisory Group, said, as quoted by CNBC.

As noted by PFE Chairman and CEO Albert Bourla, “It is a great day for science. It is a great day for humanity when you realize your vaccine has 90% effectiveness. That’s overwhelming,” Bourla said on CNBC.  “You understand that the hopes of billions of people and millions of businesses and hundreds of governments that were felt on our shoulders, now… I think we can see light at the end of the tunnel.”

Zoom Technologies (ZM)

Stay at home stocks, like Zoom Technologies (ZM) began to fall apart on that vaccine news, too.  “We’re making the assumption that everything is going to be back to normal tomorrow, and taking back some of the reward that was meted out to the stay-at-home names,” Art Hogan, chief market strategist at National Securities, as quoted by CBS News.

Canopy Growth (CGC)

Canopy Growth (CGC) saw higher highs on election night results.  For example New Jersey and Arizona voted to approve amendments to legalize the use of green for those above the age of 21.  Voters in South Dakota approved it for medical use.  Montana voted to legalize, regulate and tax recreational green for adults 21 and older.

Those and 11 other states — Washington, Oregon, California, Nevada, Colorado, Michigan, Illinois, Maine, Vermont, Massachusetts, Alaska, and the District of Columbia already allow legal recreational use.  And we have to consider that with Joe Biden in the White House, he could be more willing to legalize on a national level.

Beyond Meat (BYND)

Beyond Meat (BYND) slipped more than $25 a share after COVID-19 took a bite out of earnings.  The company posted a loss of $19.3 million, or 31 cents a share, as compared to net income of $4.1 million, or six cents a share year over year. Revenue was up 3% to $94.4 million from $92 million year over year. 

“Our financial results reflect a quarter where for the first time since the pandemic began, we experienced the full brunt and unpredictability of COVID-19 on our net revenues and accordingly, throughout our P&L,” Beyond Meat Chief Executive Ethan Brown said, as quoted by MarketWatch.

At time of this writing, Ian Cooper does not hold a position in any of the stocks mentioned.

Want More Great Investing Ideas?

Download free the “10-Step Options Trading Checklist” you need before making a trade.

Have You Downloaded Your Copy of the "Beginner's Options Guide"?

Own This Stock Before the 24th | Top Dividend Stock to Own | Download Free Report Today


PFE shares fell $0.10 (-0.26%) in after-hours trading Wednesday. Year-to-date, PFE has gained 2.28%, versus a 12.41% rise in the benchmark S&P 500 index during the same period.



About the Author: Ian Cooper

Ian Cooper, an InvestorsAlley.com contributor, has been analyzing stocks and options for advisories since 1999. Over the last 21 years, Cooper has shown thousands of investors just how to exploit “market extremes” for fast, short-term gains with seven indicators that led to successful calls on the biggest spikes and dips in the stock markets.

More...

The post Pfizer and BioNTech Stock Price Jump on COVID Vaccine News appeared first on StockNews.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear